Free Trial

UnitedHealth Group (UNH) Stock Price, News & Analysis

+7.17 (+1.42%)
(As of 07/12/2024 ET)
Today's Range
50-Day Range
52-Week Range
3.57 million shs
Average Volume
4.27 million shs
Market Capitalization
$470.81 billion
P/E Ratio
Dividend Yield
Price Target

UnitedHealth Group MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.95 Rating Score
13.7% Upside
$581.44 Price Target
Short Interest
0.84% of Float Sold Short
Dividend Strength
Based on Four Factors
Upright™ Environmental Score
News Sentiment
0.23mentions of UnitedHealth Group in the last 14 days
Based on 44 Articles This Week
Insider Trading
Proj. Earnings Growth
From $27.54 to $30.85 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.97 out of 5 stars

Medical Sector

6th out of 912 stocks

Hospital & Medical Service Plans Industry

4th out of 11 stocks

UNH stock logo

About UnitedHealth Group Stock (NYSE:UNH)

UnitedHealth Group Incorporated is a multinational, Minnetonka, Minnesota-based healthcare and insurance company. It is the result of 5 decades of mergers and acquisitions that began with the formation of Charter Med Inc in 1974. Charter Med Inc was a privately held medical services firm that was soon rebranded (1978) to United Healthcare Company. United Healthcare Company became the parent and holding company for the Physician’s Health Plan of Minnesota, an early HMO.

The company has had several key phases, including the late 1980s when it entered the pharmacy services industry; the mid-1990s when it made some major acquisitions to consolidate a large portion of the US HMO market, and the “modern” period in which it continues to pursue growth through acquisitions, expansion and deepening penetration. Among the more notable events are the inclusion of John Deere Healthcare and the restructuring of acquired assets into the Optum segment. Optum is UnitedHealth Group Incorporated’s technology-focused division and includes the staffed physical-care facilities located throughout the US.

Today, UnitedHealth Group Incorporated operates as a diversified healthcare company in the United States. It operates in four segments providing healthcare and insurance products globally. The company’s four segments are UnitedHealthcare, Optum Health, Optum Insight and Optum Rx. It is the world’s 7th largest company by revenue and the largest insurer by annual premiums. It is ranked 11th on the Forbes Fortune 500 list and had a market capitalization of nearly $500 billion at the end of 2022. Total revenue in 2022 topped $320 billion.

On a segment basis, The UnitedHealthcare segment is the largest and comprises roughly 80% of the net business. It offers consumer-oriented health benefit plans for businesses and consumers and preventative and well-being services for people over 50. It also manages Medicaid plans, family health plans and dental plans among other services.

The OptumHealth segment is a consumer-oriented platform to access a care providers and services network. The OptumInsight segment provides technology, services and outsourcing to hospitals, physicians and organizations that provide health insurance and/or health plans. The OptumRx segment serves the pharmacy industry including the retail market, home delivery and specialty services. Optum users can connect to physicians, schedule appointments, and even fill their prescriptions.

UnitedHealth Group has a long track record of dividend payments that dates back to 1990. The company also has a track record for increasing its dividend if not on a consistent annual basis. The company does not have a dividend reinvestment plan.

UnitedHealth Group is committed to sustainable operations for its consumers and the planet. To that end, the company has committed to efforts that help control healthcare costs, including telehealth and value-based arrangement with providers. Regarding the environment, the company has committed to net-zero emissions by 2035 which is well ahead of the global target. The company is also committed to health equity or the idea that healthcare opportunities (including employment) be fairly and equitably available to all.

UNH Stock Price History

UNH Stock News Headlines

Stethoscope with US dollar banknotes on chart and graph paper, Finance, Account, Statistics, Investment, Analytic research data economy and Business company concept.
Top 4 Must-Have Healthcare Stocks for Long-Term Growth
The healthcare industry represents a substantial and dynamic market sector, presenting many opportunities for investors seeking long-term growth and stability. Factors such as the aging population, technological advances, and rising healthcare costs provide the sector with a compelling combination of growth potential and resilience.
Stethoscope with US dollar banknotes on chart and graph paper, Finance, Account, Statistics, Investment, Analytic research data economy and Business company concept.
Top 4 Must-Have Healthcare Stocks for Long-Term Growth (UNH)
Investing in healthcare offers long-term growth and stability fueled by demographic trends, technological advancements, and rising demand.
Automatic Income (from home)
Everyone’s talking about this new income hack that could generate triple digit returns on your money. But here’s the best part…
Background of Stock heatmap on the monitor in predominantly red
The Top 3 Sectors Poised For Growth This Summer (UNH)
Communications, technology, and healthcare are the three hottest sectors for growth, but not all stocks will rise with the tides.
Automatic Income (from home)
Everyone’s talking about this new income hack that could generate triple digit returns on your money. But here’s the best part…
UnitedHealth Group (NYSE:UNH) Raised to Buy at
See More Headlines
Receive UNH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for UnitedHealth Group and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
Ex-Dividend for 6/25 Dividend
Dividend Payable
Next Earnings (Confirmed)
Fiscal Year End

Industry, Sector and Symbol

Hospital & medical service plans
Managed Health Care
Year Founded

Price Target and Rating

Average Stock Price Target
High Stock Price Target
Low Stock Price Target
Potential Upside/Downside
Consensus Rating
Moderate Buy
Rating Score (0-4)
Research Coverage
20 Analysts


Net Income
$22.38 billion
Pretax Margin


Sales & Book Value

Annual Sales
$371.62 billion
Cash Flow
$29.77 per share
Book Value
$102.08 per share


Free Float
Market Cap
$470.81 billion

Social Links

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Key Executives

  • Sir Andrew Philip Witty (Age 59)
    CEO & Non-Independent Director
    Comp: $3.53M
  • Mr. John F. RexMr. John F. Rex (Age 62)
    President & CFO
    Comp: $2.67M
  • Mr. Rupert Bondy (Age 62)
    Executive VP, Chief Legal Officer & Corporate Secretary
    Comp: $1.92M
  • Mr. Brian Robert ThompsonMr. Brian Robert Thompson (Age 49)
    Chief Executive Officer of UnitedHealthcare
    Comp: $2.22M
  • Mr. Thomas Edward Roos (Age 51)
    Senior VP & Chief Accounting Officer
  • Mr. Sandeep Dadlani (Age 49)
    Executive VP and Chief Digital & Technology Officer
  • Mr. Zachary William Sopcak
    Senior Vice President of Capital Markets Communications & Investor Relations
  • Ms. Jennifer Mound Smoter
    Senior VP & Chief Communications Officer
  • Mr. James T. Barry Jr. (Age 78)
    Director of Sales for Western Pennsylvania
  • Mr. Terry M. Clark
    Executive VP & Chief Marketing Officer

Should I Buy UnitedHealth Group Stock? UNH Pros and Cons Explained


Here are some ways that investors could benefit from investing in UnitedHealth Group:

  • UnitedHealth Group has consistently increased its dividend over time, providing investors with a reliable income stream. The recent dividend increase from $1.88 to $2.10 per share showcases the company's commitment to rewarding shareholders.
  • Strong financial performance with a return on equity of 26.50% and a net margin of 4.05% indicates efficient management of resources and profitability, which can be attractive to investors seeking stable returns.
  • Positive analyst ratings and target price projections suggest a favorable outlook for the company's stock, with most analysts giving a buy or strong buy rating, indicating confidence in UnitedHealth Group's future growth potential.
  • Stable market capitalization of $449.16 billion and a consistent track record of revenue growth, such as the 8.6% increase in revenue year-over-year, demonstrate the company's resilience and ability to generate value for investors.
  • UnitedHealth Group's stock price has shown resilience within a reasonable range, with a 12-month low of $436.38 and a high of $554.70, providing investors with a sense of stability and potential for capital appreciation.


Investors should be bearish about investing in UnitedHealth Group for these reasons:

  • The company's debt-to-equity ratio of 0.69 may raise concerns about its leverage levels, as a higher ratio indicates higher financial risk and potential vulnerability to economic downturns or interest rate fluctuations.
These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Sunday, July 7, 2024. Please send any questions or comments about these UnitedHealth Group pros and cons to

UNH Stock Analysis - Frequently Asked Questions

How have UNH shares performed this year?

UnitedHealth Group's stock was trading at $526.47 on January 1st, 2024. Since then, UNH stock has decreased by 2.8% and is now trading at $511.53.
View the best growth stocks for 2024 here

How were UnitedHealth Group's earnings last quarter?

UnitedHealth Group Incorporated (NYSE:UNH) posted its earnings results on Tuesday, April, 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, topping the consensus estimate of $6.63 by $0.28. The company's revenue for the quarter was up 8.6% on a year-over-year basis.
Read the conference call transcript

What is Dave Wichmann's approval rating as UnitedHealth Group's CEO?

1,269 employees have rated UnitedHealth Group Chief Executive Officer Dave Wichmann on Dave Wichmann has an approval rating of 78% among the company's employees.

Does UnitedHealth Group have any subsidiaries?

UnitedHealth Group subsidiaries include LHC Group, PreferredOne, divvyDOSE, Diplomat Pharmacy, PatientsLikeMe, Equian, Avella Specialty Pharmacy, and more.

Who are UnitedHealth Group's major shareholders?

UnitedHealth Group's top institutional shareholders include Manning & Napier Advisors LLC (0.03%), DNB Asset Management AS (0.03%), Gateway Investment Advisers LLC (0.02%) and QRG Capital Management Inc. (0.02%). Insiders that own company stock include Richard T Burke, Stephen J Hemsley, John F Rex, Andrew Witty, Dirk C Mcmahon, Thomas E Roos, Frederick William Mcnabb III, Erin Mcsweeney and Paul R Garcia.
View institutional ownership trends

How do I buy shares of UnitedHealth Group?

Shares of UNH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of UnitedHealth Group own?

Based on aggregate information from My MarketBeat watchlists, some other companies that UnitedHealth Group investors own include NVIDIA (NVDA), Visa (V), Walt Disney (DIS), Johnson & Johnson (JNJ), Home Depot (HD), Alibaba Group (BABA) and JPMorgan Chase & Co. (JPM).

This page (NYSE:UNH) was last updated on 7/14/2024 by Staff

From Our Partners